About us

C-RAD’s cutting-edge solutions ensure exceptionally high precision, safety and efficiency in advanced radiation therapy, helping to cure more cancer patients and improve their quality of life. In new advanced radiation therapy techniques, the radiation dose must be delivered to the tumor with extremely high precision and microsecond timing. Our positioning and scanning products assure just that.

Increased Accuracy

Patient Safety

Optimized Workflow

Clinical Confidence

Supporting the entire radiation therapy chain

C-RAD’s high-performance products support integration in end-to-end multi-vendor treatment workflows, from
the computed tomography room to the treatment room. The c4D interface acts as a universal software interface
to other vendors’ systems. Support is assured for patient compliance and advanced quality assurance procedures.

View our products

Company background

C-RAD was founded in 2004. The founders are researchers from Karolinska Institutet and the Royal Institute of Technology in Stockholm, clinics at Karolinska Hospital in Solna and people with extensive industrial experience in the field of radiation therapy.

The first product was launched in 2006, when C-RAD introduced the Sentinel™ system, which was based on laser scanning technology and the c4D software platform. The technology has constantly evolved since the first deliveries were made in 2007. In 2011 C-RAD launched the Catalyst™ system, a next-generation optical surface scanning system. Catalyst HD™ was released in December 2013 and in April 2015, C-RAD released a specific version of Catalyst for use in proton and particle therapy. In June 2015, C-RAD also completed its acquisition of the Franco-Belgian Cyrpa group, which added their innovative laser solutions for patient positioning and virtual simulation to the C-RAD portfolio.

View management team
Our mission is global in scope

Global sales & service network

The C-RAD Group is headquartered in Uppsala, Sweden. It has additional sales and service offices situated all over the world, both wholly owned and in collaboration with trusted distributors.

View location details

“C-RAD allows us to in real time manage the motion that the patient has as they breathe…
C-RAD will allow us to completely avoid the heart and deliver the radiation precisely accurately to their breasts only…”

nch logo
Stephen S. Nigh, M.D.
Radiation Oncology, Medical Director of Cancer Services
Northwest Community Healthcare, US
View more testimonials

Stephen Nigh, M.D. discusses the C-RAD Optical Surface Monitoring System

Latest Press releases & Events

2022-07-21 08:30 RECORD ORDER INTAKE AND RECORD HIGH ORDER BACKLOG News English Regulatory MAR VPML Report Interim Q2 IR
2022-07-21 08:30 REKORD I ORDERINGÅNG OCH REKORDHÖG ORDERSTOCK News Swedish Regulatory MAR VPML Report Interim Q2 IR
2022-07-19 08:30 Reminder: C-RAD Web Presentation Interim Report Q2 2022 News Corporate Information Presentation English IR
2022-07-15 08:30 CFO leaves C-RAD in November News Corporate Information Staff change English Regulatory Listing Regulation IR

Contact us

How can we help you?

Contact us about our products or service support

Send us a message

Contact your local office

We have service support groups the USA, China, Germany, France & Sweden

Contact us